Month: April 2017

0

Clinical Research Industry: Changing Dynamics of Clinical Research Organizations – Part 1

Posted by

Clinical research industry has grown to be an integral part of bigger pharmaceutical industry today. It helps pharma companies conduct research faster and in much more productive ways. In today’s drug development cost of 2.6 billion per new molecule, clinical trials holds about 70% share, which means that any changes in this industry affects the […]

Read More →
0

Critical Factors in Selecting a CRO: from Frost & Sullivan white paper

Posted by

Outsourcing in clinical trial industry has been on the rise for last several decades. This has been due to a combination of several factors, including increasing cost of research, blockbuster molecules going off-patent causing revenue loss and lack of extensive in-house R&D infrastructure. This has resulted in an interesting situation, where increasingly more clinical trials […]

Read More →